Log in to your Inderes Free account to see all free content on this page.
OssDsign
5.87 SEK
-2.17 %
Less than 1K followers
OSSD
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for OssDsign
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.7 | 41.4 | 133.9 | 44.5 | 46.5 | 44.0 | 45.1 | 180.2 |
| EBITDA | -9.8 | -12.3 | -49.4 | -12.7 | -6.9 | -5.5 | ||
| EBIT | -9.8 | -12.3 | -49.4 | -12.7 | -6.9 | -5.5 | -21.6 | -46.8 |
| EBIT-% | -27.5 % | -29.6 % | -36.9 % | -28.5 % | -14.9 % | -12.6 % | -47.8 % | -26.0 % |
| Profit before taxes | -9.8 | -12.6 | -49.1 | -14.7 | -7.9 | -5.6 | -22.0 | -50.2 |
| Net income | -9.8 | -13.1 | -49.7 | -14.6 | -8.3 | -5.8 | -22.3 | -51.0 |
Login required
This content is only available for logged in users